Browsing J. Other (The Hilltop Institute, UMBC) by Title
Now showing items 1-5 of 5
-
Dynamics of biosimilar uptake in emerging markets
(Taylor & Francis, 2022-05-22)Introduction Globally, biosimilars are expected to play a key role in lowering healthcare costs and providing increased patient access to biological therapies. Given this, and in line with the European Union and World ... -
Hospital Price Transparency: Will It Lead to Lower Prices?
(The Hilltop Institute, 2021-08-23) -
How New Data On Hospital “Discounted Cash Prices” Might Lead To Patient Savings
(Health Affairs, 2021-11-08) -
State Medicaid Agencies’ Multi-Faceted Response to the Opioid Epidemic
(Academy Health, 2021-09-29)Context: Medicaid is the primary payer for substance use disorder (SUD) treatment in the United States. While some policy changes have been well documented, the operational decisions that guide the implementation of ... -
States Experiment with Cross State Comparison to Evaluate Medicaid Waivers for Substance Use Disorder Services
(Academy Health, 2020-01-30)